GovWire

Guidance: Pneumococcal vaccination: guidance for health professionals

Public Health England

July 23
08:20 2020

Pneumococcal vaccination: guidance for HCWs on the changes to the infant schedule

This file may not be suitable for users of assistive technology. Request an accessible format.

If you use assistive technology (such as a screen reader) and need aversion of this document in a more accessible format, please email publications@phe.gov.uk.Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

The UK pneumococcal conjugate vaccine (PCV) immunisation programme has successfully achieved high levels of population (herd) protection for all age groups.

Currently, circulation of the 13 pneumococcal serotypes contained in the vaccine, and therefore, the risk of disease due to these serotypes, even in those at higher risk, is very low in the UK.

The PCV13 immunisation schedule has therefore been changed as follows:

  • infants born on or after 1 January 2020 should be offered a single dose of PCV13 alongside their routine DTaP/IPV/Hib/HepB and rotavirus immunisations at 12 weeks of age, followed by a PCV13 booster at one year of age (on or after their first birthday). This will be referred to as the 1+1 PCV13 schedule

  • infants born on or before 31 December 2019 will continue to receive two doses of PCV13 vaccine alongside their routine immunisations at 8 and 16 weeks of age, followed by a PCV13 booster at one year of age (on or after their first birthday). This will be referred to as the 2+1 PCV13 schedule

The one-year booster dose should be given regardless of the number of doses given under one year of age.

Published 13 December 2019
Last updated 23 July 2020 +show all updates
  1. Revised guidance and a reminder about the one-year booster dose.

  2. First published.

Related Articles

Comments

  1. We don't have any comments for this article yet. Why not join in and start a discussion.

Write a Comment

Your name:
Your email:
Comments:

Post my comment

Recent Comments

Follow Us on Twitter

Share This


Enjoyed this? Why not share it with others if you've found it useful by using one of the tools below: